MCRB Stock Summary

• Seres Therapeutics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 4.56% of US listed stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at -2.96 for Seres Therapeutics Inc; that's greater than it is for just 3.64% of US stocks.
• As for revenue growth, note that MCRB's revenue has grown 81.27% over the past 12 months; that beats the revenue growth of 93.14% of US companies in our set.
• If you're looking for stocks that are quantitatively similar to Seres Therapeutics Inc, a group of peers worth examining would be IDRA, AGIO, ORMP, CNAT, and WVE.
• Visit MCRB's SEC page to see the company's official filings. To visit the company's web site, go to www.serestherapeutics.com.